Sun Pharmaceutical Industries, based in India, will acquire DUSA Pharmaceuticals, aiming to advance into the dermatologic market in the United States.
The Mainstream Patient: February 7
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
The Art of Smelling Good
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
The Weekly Roundup: January 30-February 3
Losing a Malpractice Case May Depend on Where You Live
2 Clarke Drive Cranbury, NJ 08512